JP2012500258A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012500258A5 JP2012500258A5 JP2011523801A JP2011523801A JP2012500258A5 JP 2012500258 A5 JP2012500258 A5 JP 2012500258A5 JP 2011523801 A JP2011523801 A JP 2011523801A JP 2011523801 A JP2011523801 A JP 2011523801A JP 2012500258 A5 JP2012500258 A5 JP 2012500258A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- enzyme
- group
- compound
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000001072 heteroaryl group Chemical group 0.000 claims description 30
- -1 alkyl phosphates Chemical class 0.000 claims description 29
- 125000000623 heterocyclic group Chemical group 0.000 claims description 28
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 27
- 125000003118 aryl group Chemical group 0.000 claims description 26
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 24
- 125000000217 alkyl group Chemical group 0.000 claims description 24
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 24
- 150000001875 compounds Chemical class 0.000 claims description 18
- 125000003342 alkenyl group Chemical group 0.000 claims description 16
- 125000001424 substituent group Chemical group 0.000 claims description 16
- 102000004190 Enzymes Human genes 0.000 claims description 15
- 108090000790 Enzymes Proteins 0.000 claims description 15
- 229910019142 PO4 Inorganic materials 0.000 claims description 15
- 235000021317 phosphate Nutrition 0.000 claims description 15
- 108060001084 Luciferase Proteins 0.000 claims description 14
- 239000000539 dimer Substances 0.000 claims description 13
- 229910052757 nitrogen Inorganic materials 0.000 claims description 13
- 239000005089 Luciferase Substances 0.000 claims description 11
- 229910052739 hydrogen Inorganic materials 0.000 claims description 11
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 11
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 claims description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 10
- 229910052760 oxygen Inorganic materials 0.000 claims description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 9
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 9
- 239000010452 phosphate Substances 0.000 claims description 9
- 229910052717 sulfur Inorganic materials 0.000 claims description 8
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 claims description 7
- 125000003545 alkoxy group Chemical group 0.000 claims description 7
- 125000000304 alkynyl group Chemical group 0.000 claims description 7
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 7
- 239000001257 hydrogen Substances 0.000 claims description 7
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 7
- 125000004642 (C1-C12) alkoxy group Chemical group 0.000 claims description 6
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 6
- 125000006728 (C1-C6) alkynyl group Chemical group 0.000 claims description 6
- 125000006649 (C2-C20) alkynyl group Chemical group 0.000 claims description 6
- 125000006651 (C3-C20) cycloalkyl group Chemical group 0.000 claims description 6
- 125000005915 C6-C14 aryl group Chemical group 0.000 claims description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 6
- 125000005110 aryl thio group Chemical group 0.000 claims description 6
- 125000004122 cyclic group Chemical group 0.000 claims description 6
- 150000001204 N-oxides Chemical class 0.000 claims description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- 239000000758 substrate Substances 0.000 claims description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 4
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims description 4
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 4
- 125000004414 alkyl thio group Chemical group 0.000 claims description 4
- 125000005135 aryl sulfinyl group Chemical group 0.000 claims description 4
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 229910052731 fluorine Inorganic materials 0.000 claims description 4
- 125000005150 heteroarylsulfinyl group Chemical group 0.000 claims description 4
- 125000005143 heteroarylsulfonyl group Chemical group 0.000 claims description 4
- 125000000468 ketone group Chemical group 0.000 claims description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 4
- 125000004399 C1-C4 alkenyl group Chemical group 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims description 3
- 125000005600 alkyl phosphonate group Chemical group 0.000 claims description 3
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 3
- 150000001720 carbohydrates Chemical class 0.000 claims description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 3
- YGBFLZPYDUKSPT-MRVPVSSYSA-N cephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)C[C@H]21 YGBFLZPYDUKSPT-MRVPVSSYSA-N 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- 125000005223 heteroarylcarbonyl group Chemical group 0.000 claims description 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 150000003384 small molecules Chemical class 0.000 claims description 3
- 125000003107 substituted aryl group Chemical group 0.000 claims description 3
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims description 3
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 claims description 3
- 125000003396 thiol group Chemical class [H]S* 0.000 claims description 3
- 238000000034 method Methods 0.000 claims 14
- 241001465754 Metazoa Species 0.000 claims 6
- 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 claims 5
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 claims 5
- 230000000694 effects Effects 0.000 claims 5
- 125000001475 halogen functional group Chemical group 0.000 claims 4
- 230000001404 mediated effect Effects 0.000 claims 4
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 238000004020 luminiscence type Methods 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 239000011541 reaction mixture Substances 0.000 claims 3
- 230000002255 enzymatic effect Effects 0.000 claims 2
- 241000254173 Coleoptera Species 0.000 claims 1
- 102000004328 Cytochrome P-450 CYP3A Human genes 0.000 claims 1
- 108010081668 Cytochrome P-450 CYP3A Proteins 0.000 claims 1
- 101000953909 Streptomyces viridifaciens Isobutylamine N-hydroxylase Proteins 0.000 claims 1
- 108700019146 Transgenes Proteins 0.000 claims 1
- 125000004104 aryloxy group Chemical group 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 239000013592 cell lysate Substances 0.000 claims 1
- 210000003850 cellular structure Anatomy 0.000 claims 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 claims 1
- 230000009261 transgenic effect Effects 0.000 claims 1
- 125000005647 linker group Chemical group 0.000 description 17
- 125000005843 halogen group Chemical group 0.000 description 11
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 125000000714 pyrimidinyl group Chemical group 0.000 description 3
- 125000006413 ring segment Chemical group 0.000 description 3
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 2
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 2
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 description 2
- 125000002619 bicyclic group Chemical group 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 125000002541 furyl group Chemical group 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- 125000002883 imidazolyl group Chemical group 0.000 description 2
- 125000002950 monocyclic group Chemical group 0.000 description 2
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- 125000000641 acridinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 125000002877 alkyl aryl group Chemical group 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 1
- 125000001589 carboacyl group Chemical group 0.000 description 1
- 125000004181 carboxyalkyl group Chemical group 0.000 description 1
- 125000004230 chromenyl group Chemical group O1C(C=CC2=CC=CC=C12)* 0.000 description 1
- 125000000259 cinnolinyl group Chemical group N1=NC(=CC2=CC=CC=C12)* 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- UZVGSSNIUNSOFA-UHFFFAOYSA-N dibenzofuran-1-carboxylic acid Chemical compound O1C2=CC=CC=C2C2=C1C=CC=C2C(=O)O UZVGSSNIUNSOFA-UHFFFAOYSA-N 0.000 description 1
- 125000003838 furazanyl group Chemical group 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000001977 isobenzofuranyl group Chemical group C=1(OC=C2C=CC=CC12)* 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- 125000005956 isoquinolyl group Chemical group 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 125000004593 naphthyridinyl group Chemical group N1=C(C=CC2=CC=CN=C12)* 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 125000004043 oxo group Chemical group O=* 0.000 description 1
- 125000004934 phenanthridinyl group Chemical group C1(=CC=CC2=NC=C3C=CC=CC3=C12)* 0.000 description 1
- 125000004625 phenanthrolinyl group Chemical group N1=C(C=CC2=CC=C3C=CC=NC3=C12)* 0.000 description 1
- 125000001484 phenothiazinyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 description 1
- 125000004932 phenoxathinyl group Chemical group 0.000 description 1
- 125000001644 phenoxazinyl group Chemical group C1(=CC=CC=2OC3=CC=CC=C3NC12)* 0.000 description 1
- 125000001997 phenyl group Chemical class [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 description 1
- 239000000651 prodrug Chemical group 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 125000001042 pteridinyl group Chemical group N1=C(N=CC2=NC=CN=C12)* 0.000 description 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000004627 thianthrenyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3SC12)* 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000000464 thioxo group Chemical group S=* 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- 125000001834 xanthenyl group Chemical group C1=CC=CC=2OC3=CC=CC=C3C(C12)* 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8981808P | 2008-08-18 | 2008-08-18 | |
| US61/089,818 | 2008-08-18 | ||
| PCT/US2009/004696 WO2010021686A1 (en) | 2008-08-18 | 2009-08-18 | Luminogenic compounds and methods to detect cytochrome p450 3a enzymes |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012500258A JP2012500258A (ja) | 2012-01-05 |
| JP2012500258A5 true JP2012500258A5 (cg-RX-API-DMAC10.html) | 2012-10-04 |
| JP5597200B2 JP5597200B2 (ja) | 2014-10-01 |
Family
ID=41227208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011523801A Active JP5597200B2 (ja) | 2008-08-18 | 2009-08-18 | ルミネッセンスを生じる化合物およびチトクロムp4503a酵素を検出するための方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US8288559B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP2323996B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP5597200B2 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2010021686A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1546162B1 (en) | 2002-09-20 | 2011-06-22 | Promega Corporation | Luminescence-based methods and probes for measuring cytochrome p450 activity |
| EP2778234B1 (en) | 2005-05-31 | 2017-09-27 | Promega Corporation | Luminogenic and fluorogenic compounds and methods to detect molecules or conditions |
| WO2010021686A1 (en) | 2008-08-18 | 2010-02-25 | Promega Corporation | Luminogenic compounds and methods to detect cytochrome p450 3a enzymes |
| WO2014159044A1 (en) * | 2013-03-12 | 2014-10-02 | Promega Corporation | Red-shifted luciferins and methods of using same |
| US11072812B2 (en) | 2013-03-15 | 2021-07-27 | Promega Corporation | Substrates for covalent tethering of proteins to functional groups or solid surfaces |
| US9790537B2 (en) | 2014-01-29 | 2017-10-17 | Promega Corporation | Quinone-masked probes as labeling reagents for cell uptake measurements |
| US9732373B2 (en) * | 2014-09-11 | 2017-08-15 | Promega Corporation | Luciferase sequences utilizing infrared-emitting substrates to produce enhanced luminescence |
| ES2974634T3 (es) | 2018-12-21 | 2024-06-28 | Celgene Corp | Inhibidores de tienopiridinas de RIPK2 |
| CN111100089A (zh) * | 2019-12-30 | 2020-05-05 | 四川大学华西医院 | 一种检测亚硫酸盐的生物发光探针及其制备方法和用途 |
| WO2022050233A1 (ja) * | 2020-09-03 | 2022-03-10 | 黒金化成株式会社 | 発光システム及びシトクロムp450の定量方法 |
Family Cites Families (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2929115A1 (de) | 1979-07-18 | 1981-02-12 | Boehringer Mannheim Gmbh | Verfahren zur herstellung von luciferin |
| US4665022A (en) | 1984-02-17 | 1987-05-12 | The Regents Of The University Of California | Bioluminescent assay reagent and method |
| JPS6124741A (ja) | 1984-07-12 | 1986-02-03 | 名取 通弘 | 関節型伸展トラスビ−ム |
| DE3537877A1 (de) | 1985-10-24 | 1987-04-30 | Geiger Reinhard | Luciferin-derivate und immunoassays unter einsatz derartiger luciferin-derivate |
| DE3700908A1 (de) | 1987-01-14 | 1988-07-28 | Geiger Reinhard | Aminoluciferine, verfahren zu deren herstellung und deren verwendung bei der bestimmung von enzymaktivitaeten |
| AU609824B2 (en) | 1987-06-15 | 1991-05-09 | Southern Cross Biotech Pty Ltd. | Production of proteins in active forms |
| US5498523A (en) | 1988-07-12 | 1996-03-12 | President And Fellows Of Harvard College | DNA sequencing with pyrophosphatase |
| US5114704A (en) | 1989-05-30 | 1992-05-19 | Nabisco Brands, Inc. | Raw hide having a coating containing an inorganic pyrophosphate |
| CA2022236A1 (en) | 1989-07-31 | 1991-02-01 | Hiroaki Yanagisawa | Coumarin derivatives, their preparation and their use in the treatment of cerebrovascular disorders |
| JP3117994B2 (ja) | 1990-05-16 | 2000-12-18 | ベイラー・カレツジ・オブ・メデイシン | 永久的ヒト肝細胞の細胞系および肝臓補助装置(lad)におけるその使用 |
| US5374534A (en) | 1990-07-19 | 1994-12-20 | Charm Sciences, Inc. | Method of preparing D-luciferin derivatives |
| US5283180A (en) | 1990-07-19 | 1994-02-01 | Charm Sciences, Inc. | Bioluminescence method for the determination of pesticides |
| US5283179A (en) | 1990-09-10 | 1994-02-01 | Promega Corporation | Luciferase assay method |
| US5840739A (en) | 1992-11-16 | 1998-11-24 | University Of Florida Research Foundation, Inc. | Thiazoline acid derivatives |
| EP0675955A1 (en) | 1992-12-23 | 1995-10-11 | Iowa State University Research Foundation, Inc. | Molecular flashlight |
| US6676967B1 (en) | 1993-09-20 | 2004-01-13 | Kos Pharmaceuticals, Inc. | Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia |
| US5650135A (en) | 1994-07-01 | 1997-07-22 | The Board Of Trustees Of The Leland Stanford Junior University | Non-invasive localization of a light-emitting conjugate in a mammal |
| US6217847B1 (en) | 1994-07-01 | 2001-04-17 | The Board Of Trustees Of The Leland Stanford Junior University | Non-invasive localization of a light-emitting conjugate in a mammal |
| JP3648763B2 (ja) | 1994-08-23 | 2005-05-18 | 日本油脂株式会社 | ウミホタルルシフェリン誘導体および糖加水分解酵素の定量方法 |
| JPH08224096A (ja) | 1995-02-20 | 1996-09-03 | Sapporo Breweries Ltd | 微生物検査用培地と該培地を用いた微生物検査方法 |
| AU5259296A (en) | 1995-04-07 | 1996-10-23 | Warner-Lambert Company | Flavones and coumarins as agents for the treatment of athero sclerosis |
| US5744320A (en) | 1995-06-07 | 1998-04-28 | Promega Corporation | Quenching reagents and assays for enzyme-mediated luminescence |
| WO1997008342A1 (en) | 1995-08-30 | 1997-03-06 | Gentest Corporation | Cytochrome p450 reporter gene |
| US5902732A (en) | 1995-10-04 | 1999-05-11 | Cytoscan Sciences Llc | Drug screening process measuring changes in cell volume |
| US6291164B1 (en) | 1996-11-22 | 2001-09-18 | Invitrogen Corporation | Methods for preventing inhibition of nucleic acid synthesis by pyrophosphate |
| US5876946A (en) | 1997-06-03 | 1999-03-02 | Pharmacopeia, Inc. | High-throughput assay |
| US6302685B1 (en) * | 1997-09-16 | 2001-10-16 | University Of Medicine And Dentistry Of New Jersey | Human lysosomal protein and methods of its use |
| US6602677B1 (en) | 1997-09-19 | 2003-08-05 | Promega Corporation | Thermostable luciferases and methods of production |
| WO1999042606A1 (en) | 1998-02-23 | 1999-08-26 | Phylonix Pharmaceuticals, Inc. | Methods of screening agents for activity using teleosts |
| US6902918B1 (en) | 1998-05-21 | 2005-06-07 | California Institute Of Technology | Oxygenase enzymes and screening method |
| US6312917B1 (en) | 1998-12-04 | 2001-11-06 | The University Of North Carolina At Chapel Hill | Method of screening candidate compounds for susceptibility to oxidative metabolism |
| US6143492A (en) | 1998-12-14 | 2000-11-07 | Aurora Biosciences Corporation | Optical molecular sensors for cytochrome P450 activity |
| DK1140888T3 (da) | 1998-12-14 | 2003-08-25 | Vertex Pharma San Diego Llc | Optiske molekylære sensorer for cytochrom P450-aktivitet |
| US6514687B1 (en) | 1998-12-14 | 2003-02-04 | Vertex Pharmaceuticals (San Diego), Llc | Optical molecular sensors for cytochrome P450 activity |
| US6420130B1 (en) | 1998-12-14 | 2002-07-16 | Aurora Biosciences Corporation | Optical molecular sensors for cytochrome P450 activity |
| JP2000270894A (ja) | 1999-03-23 | 2000-10-03 | Kikkoman Corp | D−ルシフェリン−O−β−D−グルクロニド誘導体、その製造方法、その誘導体を有効成分とするβ−グルクロニダーゼの活性測定方法、及び大腸菌の検出方法 |
| JP3618572B2 (ja) | 1999-03-24 | 2005-02-09 | キッコーマン株式会社 | D−システインの測定法 |
| US7118878B1 (en) | 2000-06-09 | 2006-10-10 | Promega Corporation | Method for increasing luminescence assay sensitivity |
| JP2002080476A (ja) | 2000-08-31 | 2002-03-19 | Iatron Lab Inc | D−ルシフェリン類縁体並びにルシフェラーゼ活性分析用試薬及びatp分析用試薬 |
| US6531297B2 (en) | 2000-10-20 | 2003-03-11 | Applera Corporation | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| EP1397678A1 (en) | 2001-06-01 | 2004-03-17 | Roche Diagnostics GmbH | Luciferin hydrazides |
| US7268229B2 (en) | 2001-11-02 | 2007-09-11 | Promega Corporation | Compounds to co-localize luminophores with luminescent proteins |
| FR2831889B1 (fr) | 2001-11-08 | 2004-01-16 | Proteus | Procede pour generer l'empreinte catalytique idiosyncrasique d'un echantillon, le traitement de ladite empreinte et les systemes pour leur mise en oeuvre |
| EP1472238B1 (en) | 2002-02-01 | 2012-07-04 | Promega Corporation | Bioluminescent protease assay |
| EP1487261B1 (en) | 2002-03-05 | 2008-08-27 | MCW Research Foundation, Inc. | Methods and compositions for pharmacological and toxicological evaluation of test agents |
| AU2003270554A1 (en) | 2002-09-09 | 2004-03-29 | Applera Corporation | Fluorescent enzyme assay methods and compositions |
| EP1546162B1 (en) * | 2002-09-20 | 2011-06-22 | Promega Corporation | Luminescence-based methods and probes for measuring cytochrome p450 activity |
| WO2004059294A2 (en) | 2002-12-23 | 2004-07-15 | Promega Corporation | Improved luciferase-based assays |
| WO2005007663A2 (en) | 2003-07-14 | 2005-01-27 | Irm Llc | Fluorogenic enzyme substrates and uses thereof |
| RU2242471C1 (ru) | 2003-07-31 | 2004-12-20 | Азад Зияд Оглы Абышев | Производные 2-н-1-бензопиран-2-она, проявляющие антикальциевую активность |
| US6913545B2 (en) * | 2003-07-31 | 2005-07-05 | Karsten Manufacturing Corporation | Golf club head having a face insert with a visual outline |
| US20080194522A1 (en) | 2004-08-25 | 2008-08-14 | Gong Chen | Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B) |
| EP2778234B1 (en) | 2005-05-31 | 2017-09-27 | Promega Corporation | Luminogenic and fluorogenic compounds and methods to detect molecules or conditions |
| JP4899046B2 (ja) | 2005-09-30 | 2012-03-21 | 国立大学法人 東京大学 | 新規ルシフェリン誘導体 |
| CN101573357B (zh) * | 2006-10-19 | 2013-01-23 | 武田药品工业株式会社 | 吲哚化合物 |
| WO2010021686A1 (en) | 2008-08-18 | 2010-02-25 | Promega Corporation | Luminogenic compounds and methods to detect cytochrome p450 3a enzymes |
-
2009
- 2009-08-18 WO PCT/US2009/004696 patent/WO2010021686A1/en not_active Ceased
- 2009-08-18 JP JP2011523801A patent/JP5597200B2/ja active Active
- 2009-08-18 US US12/543,376 patent/US8288559B2/en active Active
- 2009-08-18 EP EP09789154.3A patent/EP2323996B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2568769T3 (es) | Derivados de piperazina y su uso como agentes terapéuticos | |
| ES2732230T3 (es) | Compuestos que anulan el punto de control G2 del ciclo celular para una utilización en el tratamiento del cáncer | |
| ES2377406T3 (es) | Derivados de la piperazina y su uso como agentes terapéuticos | |
| Wang et al. | Inhibitors of human immunodeficiency virus type 1 (HIV-1) attachment. 5. An evolution from indole to azaindoles leading to the discovery of 1-(4-benzoylpiperazin-1-yl)-2-(4, 7-dimethoxy-1H-pyrrolo [2, 3-c] pyridin-3-yl) ethane-1, 2-dione (BMS-488043), a drug candidate that demonstrates antiviral activity in HIV-1-infected subjects | |
| ES2386353T3 (es) | Derivados de piridazina y su uso como agentes terapéuticos | |
| ES2359840T3 (es) | Derivados de piridina para inhibición de estearoil-coa-desaturasa humana. | |
| ES2552684T3 (es) | Nuevos compuestos de imidazolidina como moduladores del receptor de andrógenos | |
| RS61381B1 (sr) | Derivat policikličnog piridona protiv gripa i njegov prolek | |
| JP2008545746A5 (cg-RX-API-DMAC10.html) | ||
| JP2002523450A5 (cg-RX-API-DMAC10.html) | ||
| Pace et al. | The monoethyl ester of meconic acid is an active site inhibitor of HCV NS5B RNA-dependent RNA polymerase | |
| HUP0400851A2 (hu) | Dihidro-benzo[b][1,4]diazepin-2-on-származékok, mint MGluR2 II antagonisták, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| BRPI0718966B8 (pt) | composto, composição farmacêutica, inibidor plk1 e agente antitumoral | |
| CY1111876T1 (el) | Νεες πυρρολες με υπολiπiδaiμiκες και υποχοληστερολαιμικες δραστικοτητες, μεθοδος για την παρασκευη αυτων και φαρμακευτικες συνθεσεις που τις περιεχουν και η χρηση αυτων στην ιατρικη | |
| NO20072547L (no) | 4-metoksymetyl-pyrrolidin-2-karboksylsyreforbindelser og derivater derav som hepatitt C virusinhibitorer | |
| BR9915475A (pt) | Derivados da quinolina-4-carboxamida comoantagonistas dos receptores de nk-3 e nk-2 | |
| CN103476411B (zh) | 标靶人类胸腺核苷酸激酶诱导恶性肿瘤中的dna修复毒性 | |
| JP6327431B2 (ja) | がん細胞阻害薬、がん幹細胞検出用プローブ | |
| WO2001053272A1 (en) | Human chymase inhibitors | |
| CA3202763A1 (en) | Benzene ring compound and use thereof | |
| CA2907490A1 (en) | Fluorescent-hap: a diagnostic stain for hbv cores in cells | |
| Combrink et al. | Respiratory syncytial virus fusion inhibitors. Part 6: an examination of the effect of structural variation of the benzimidazol-2-one heterocycle moiety | |
| Wang et al. | The novel benzopyran class of selective cyclooxygenase-2 inhibitors-part I: The first clinical candidate | |
| TW201908299A (zh) | 含有胺或(硫)醯胺之lxr調節劑 | |
| KR20220004206A (ko) | 키네이스 억제제로 유용한 치환된 거대고리화합물 |